Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Across the Water with Tanielle Powell: Closer Than You Think TV Series Spotlights Jersey City Real Estate and Lifestyle on REAL Shows Network
-
Lincoln Educational Services Corporation Schedules First Quarter 2026 Earnings Release And Conference Call
-
Mesa Royalty Trust Announces Trust Income for April 2026
-
Naropa University Reduces Tuition & Expands Access Through New Academic Programs & Prior Learning Pathways
-
Hyundai Hosts Emergency Responders Extrication Training in Michigan
-
Sun Life U.S. receives Top Workplaces award from Milwaukee Journal Sentinel for third consecutive year
-
Bank of America Declares Preferred Stock Dividends Payable in May and June 2026
-
UNITED BANCSHARES, INC. ANNOUNCES FIRST QUARTER 2026 RESULTS AND $0.25 DIVIDEND
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
WM Technology, Inc. Reports Preliminary First Quarter 2026 Financial Results
-
Permianville Royalty Trust Announces Monthly Cash Distribution
-
Cross Country Healthcare to Hold First Quarter 2026 Earnings Conference Call on Thursday, May 7, 2026
-
BGIN BLOCKCHAIN LIMITED Schedules the Fiscal Year 2025 Earnings and Conference Call on April 24, 2026
-
Nexgenrx Announces Declaration of Divdend
-
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Quantify Funds to Close STKd 100% NVDA & 100% AMD ETF (LAYS)
-
Zacatecas Silver Announces Investor Relations Engagement
-
TTEC Schedules First Quarter 2026 Earnings Release and Webcast of Investor Conference Call
-
Sonoco To Report First Quarter 2026 Results
-
In HelloNation, Wealth Advisor Ted Thatcher Details Estate and Legacy Planning
-
In HelloNation, Wealth Advisor Ted Thatcher Explains Managing Healthcare Costs in Retirement
-
Vera Bradley Terminates Existing Shareholder Rights Plan
-
Comfort Systems USA Announces First Quarter 2026 Conference Call and Webcast
-
Paramount Declares Quarterly Cash Dividend
-
Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting
-
Savara Announces New Employment Inducement Grant
-
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
-
Talen Energy Announces Pricing of Senior Notes
-
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Resear
-
QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option
-
SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders
-
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
-
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
4DMT Announces New Employment Inducement Grants
-
CoreWeave Announces Date of First Quarter 2026 Financial Results and Conference Call
-
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
-
VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE
-
Revolution Medicines Announces Closing of Concurrent Upsized Public Offerings with Aggregate Gross Proceeds of Approximately $2.2 Billion, Including Full Exercise of Underwriters’ Option to Purchase
-
Hingham Savings Reports First Quarter 2026 Results
-
New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer
-
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting
-
New Clinical and Preclinical Data for Investigational Candidate Zidesamtinib Presented at AACR Annual Meeting 2026
-
Kalohexis Announces Poster Presentation at the American Association for Cancer Research Annual Meeting 2026
-
New Era Energy & Digital Announces Appointment of Andy Casazza as Chief Corporate Officer
-
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
-
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
-
Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
-
Aviation Capital Group Announces Departure of Chief Financial Officer
-
Eaton Vance Limited Duration Income Fund, Eaton Vance Senior Floating-Rate Trust, and Eaton Vance Senior Income Trust Announce Tender Offers for Outstanding Auction Preferred Shares
-
NYSE to Commence Delisting Proceedings Against QVC, Inc. (QVCC, QVCD)

